SCHEDULE: FMR LLC & Abigail Johnson Update Pulmonx Stake

FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, disclosing a 0.2% beneficial ownership in Pulmonx Corporation's common stock as of October 31, 2025.

Summary

• FMR LLC and Abigail P. Johnson filed an Amendment No. 6 to Schedule 13G regarding their beneficial ownership of Pulmonx Corporation's common stock.
• As of October 31, 2025, FMR LLC and Abigail P. Johnson each beneficially own 70,825 shares of Pulmonx Corporation common stock.
• This represents 0.2% of the total outstanding common stock of Pulmonx Corporation.
• FMR LLC holds sole voting power over 60,813 shares and sole dispositive power over 70,825 shares.
• Abigail P. Johnson holds sole dispositive power over 70,825 shares, with no sole voting power.
• FMR LLC is classified as a parent holding company, and Abigail P. Johnson is an individual.
• The filing indicates that other persons have the right to receive dividends or proceeds from these securities, but no single other person's interest exceeds 5% of the total outstanding common stock.
• The filing was made jointly under a Rule 13d-1(k)(1) agreement, signed on November 6, 2025.

Sentiment

Score: 5

Explanation: The filing is a routine regulatory disclosure of beneficial ownership and does not contain information that would significantly alter the sentiment towards the company. It is neutral in nature.

Positives

• Routine disclosure of beneficial ownership by a significant institutional investor (FMR LLC) and its principal (Abigail P. Johnson) indicates continued interest in Pulmonx Corporation.
• The filing confirms FMR LLC's role as a parent holding company with various investment advisory and trust company subsidiaries holding the securities.

Negatives

• The reported beneficial ownership of 0.2% is a relatively small stake, suggesting a limited direct influence on the company's control or strategic direction by the reporting persons.
• This is an amendment, but the percentage of ownership remains at 0.2%, indicating no significant increase in stake.

Risks

• No specific risks related to Pulmonx Corporation's operations or financial health are disclosed in this ownership filing.
• The risk associated with a small ownership stake is that the reporting persons have limited ability to influence corporate decisions.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance regarding Pulmonx Corporation's future performance or strategic direction.

Industry Context

Schedule 13G filings are routine disclosures by passive investors who own less than 5% of a company's stock, or by certain institutional investors (like FMR LLC) who own more than 5% but do not intend to influence control. This filing indicates that FMR LLC, a major asset manager, continues to hold a minor, passive stake in Pulmonx Corporation, which is common practice for diversified investment portfolios.

Stakeholder Impact

• Shareholders: Provides transparency regarding the beneficial ownership structure by a major institutional investor.
• Employees, Customers, Suppliers, Creditors: No direct impact from this routine ownership disclosure.

Next Steps

• The filing does not mention any specific future actions, events, or milestones for Pulmonx Corporation or the reporting persons beyond the routine regulatory compliance.

Key Dates

Keywords

Pulmonx Corporation, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management